Takeda License Agreement definition

Takeda License Agreement means the agreement dated November 12, 1987, by and between Takeda and Chemex, predecessor in interest to Block, a copy of which is attached hereto as Exhibit K;
Takeda License Agreement means that certain License Agreement, dated as of February 1, 2008, by and between Amgen and Takeda, as amended. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Takeda License Agreement. 1 means that certain Exclusive License Agreement, dated as of September 16, 2022, by and between Millennium Pharmaceuticals, Inc., a Delaware corporation, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and the Issuer, in effect as of the Third Amendment Effective Date.

Examples of Takeda License Agreement in a sentence

  • Under the Takeda License Agreement, the Company will pay Takeda a fixed, high single-digit royalty on net sales of relugolix and MVT-602 products in the Company’s territory, subject to certain agreed reductions.

  • Under the Takeda License Agreement, there was no upfront payment and there are no payments upon the achievement of clinical development or marketing approval milestones.

  • As of June 30, 2015, inventory consisted of product held under the Global Takeda License Agreement.

  • Access has certain right, title and interest in and to the Takeda License Agreement (as hereinafter defined) and the Purchased Assets (as hereinafter defined), which includes, without limitation, certain tangible and intangible property relating to the manufacture, use, sale and distribution of the Products (as hereinafter defined).

  • The Takeda License Agreement imposes, and any future collaboration agreements or license agreements we enter into are likely to impose various development, commercialization, funding, milestone, royalty, diligence, sublicensing, insurance, patent prosecution and enforcement or other obligations on us.

  • The Takeda License Agreement imposes on us obligations relating to exclusivity, territorial restrictions, development, commercialization, funding, payment, diligence, sublicensing, insurance, intellectual property protection, and other matters.

  • If, for any reason, the Takeda License Agreement is terminated or we otherwise lose the rights thereunder, it would adversely affect our business.

  • The Nominating and Corporate Governance Committee is responsible for assessing the appropriate mix of skills and characteristics required of Board members given the present needs of the Board and shall periodically review and update the criteria as deemed appropriate.

  • If, for any reason, the Takeda License Agreement is terminated or we otherwise lose those rights, it could adversely affect our business.

  • Access and ULURU acknowledge that this Agreement does not act as a conveyance, transfer or assignment of any property but that all of the Purchased Assets and the Takeda License Agreement are conveyed, transferred or assigned by way of the Xxxx of Sale and Assignment Agreement, the Product Patents Assignment, the Product Trademarks Assignment and other documents delivered pursuant to the terms of this Agreement.


More Definitions of Takeda License Agreement

Takeda License Agreement means the Agreement by and among TSD, TPC, DP, PPD, Inc. and the Company dated July 13, 2005, as amended on October 10, 2005 and as such agreement may be amended or restated hereafter.
Takeda License Agreement means the Agreement dated May 7, 1991, as amended heretofore and from time to time hereafter, between Takeda Chemical Industries, Ltd, a Japanese corporation and BMS covering the license to BMS of certain U.S. and foreign patents covering cephalosporins, including Cefepime, starting materials, intermediates and manufacturing processes thereof.
Takeda License Agreement means the Agreement dated May 7, 1991, as amended heretofore and from time to time hereafter, between Takeda Chemical Industries, Ltd, a Japanese corporation, and BMS covering the license to BMS of certain U.S. and foreign patents covering cephalosporins, including Cefepime, starting materials, intermediates and manufacturing processes thereof. "TERM", without any other qualification, means the last to expire or terminate of the Azactam-Registered Trademark- Term or the Maxipime-Registered Trademark- Term, as set forth in Article 13 hereof.

Related to Takeda License Agreement

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • IP License Agreement shall have the meaning set forth in Section 5.3(b).

  • Patent License Agreement means the Patent License Agreement attached hereto as Exhibit H.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Software License Agreement means the particular Software License Agreement to which these Terms and Conditions are attached and incorporated into by reference.

  • Cross License Agreement means that certain Cross License Agreement between and among Medarex, Cell Genesys, Inc., Abgenix, Inc., Xenotech, L.P. and Japan Tobacco Inc., dated March 26, 1997.

  • License Agreements shall have the meaning set forth in Section 8.11 hereof.

  • Company License Agreements means any license agreements granting any right to use or practice any rights under any Intellectual Property (except for such agreements for off-the-shelf products that are generally available for less than $25,000), and any written settlements relating to any Intellectual Property, to which the Company is a party or otherwise bound; and the term “Software” means any and all computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code or object code.

  • Trademark License Agreement means that certain Trademark License Agreement in substantially the form attached hereto as Exhibit F.

  • Intercompany License Agreement means any cost sharing agreement, commission or royalty agreement, license or sub-license agreement, distribution agreement, services agreement, Intellectual Property rights transfer agreement or any related agreements, in each case where all the parties to such agreement are one or more of the Borrower and any Restricted Subsidiary thereof.

  • Intellectual Property License Agreement means the license of Intellectual Property by and between Weyerhaeuser and Newco substantially in the form attached as Exhibit B.

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Supply Agreement has the meaning set forth in Section 7.2.

  • Third Party Agreement has the meaning set forth in Section 6(a) hereof.

  • Research License means a nontransferable, nonexclusive license to make and to use the Licensed Products or the Licensed Processes as defined by the Licensed Patent Rights for purposes of research and not for purposes of commercial manufacture or distribution or in lieu of purchase.

  • Exclusivity Agreement , in relation to land, means an agreement, by the owner or a lessee of the land, not to permit any person (other than the persons identified in the agreement) to construct a solar pv station on the land;”;

  • Third Party License means licenses from third parties governing third party software embedded or used in the Trading Platform.

  • Licensing Agreement means a commercial agreement between a design approval holder and a production approval holder (or applicant) formalizing the rights and duties of both parties to use the design data for the purpose of manufacturing the product or article.

  • CREFC® Intellectual Property Royalty License Fee With respect to each Mortgage Loan (including any REO Mortgage Loan) and for any Distribution Date, the amount accrued during the related Interest Accrual Period at the CREFC® Intellectual Property Royalty License Fee Rate on, in the case of the initial Distribution Date, the Cut-Off Date Balance of such Mortgage Loan and, in the case of any subsequent Distribution Date, the Stated Principal Balance of such Mortgage Loan as of the close of business on the Distribution Date in the related Interest Accrual Period; provided that such amounts shall be computed for the same period and on the same interest accrual basis respecting which any related interest payment due or deemed due on the related Mortgage Loan is computed and shall be prorated for partial periods. For the avoidance of doubt, the CREFC® Intellectual Property Royalty License Fee shall be payable from the Lower-Tier REMIC.

  • Manufacturing Agreement has the meaning set forth in Section 4.3.

  • Company Licensed IP means all Intellectual Property rights owned or purported to be owned by a third party and licensed to the Company or any Company Subsidiary or to which the Company or any Company Subsidiary otherwise has a right to use.

  • Development Agreement has the meaning set forth in the Recitals.

  • Research Agreement means a new written contract, grant or cooperative agreement entered into between a person and a college or research corporation for the performance of qualified research; however, all qualified research costs generating a rebate must be spent by the college or research corporation on qualified research undertaken according to a research agreement.

  • Royalty Agreement means the amended royalty agreement between the Partnership, Vermilion, 1209963 Alberta Ltd. and the Trust dated January 22, 2003 providing for the creation of the Royalty;